Codiak | IPO Presentation Deck | 36 slides · page 30 of 36
The slide uses a 'Before/After' or 'Problem/Solution' structure. It includes three distinct charts showing gene expression efficiency, ocular expression, and loading enhancement.
Pitch deck · solution · present_solution · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
chart 3/3 image 2/2 paragraph 2/2 title 1/1
Components 8
bar-vertical bar-vertical line photo photo paragraph paragraph headline
Tools 2
Before-After-Bridge slide · 70%
CHALLENGES: High Dose of AAV Associated with Toxicity. Neutralizing anti-AAV antibodies (nAbs), Inadequate or fading gene expression, Limited tropism of effective AAV-vectors, High dose AAV associate
Chart Selection Guide slide · 70%chart/line: High efficiency, neutralization-resistant gene expression
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1